Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

2,204

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

October 31, 2010

Conditions
Essential Hypertension
Interventions
DRUG

Olmesartan medoxomil 40 mg - Amlodipine 10 mg

Oral tablets containing Olmesartan medoxomil-Amlodipine 40-10 mg, given once daily

DRUG

Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 12.5mg

Coated, oral tablets containing Olmesartan 40mg-Amlodipine 10mg + 1 Hydrochlorothiazide 12.5mg oral tablet + 1 Hydrochlorothiazide 12.5mg oral, placebo tablet. All tablets are given once a day.

DRUG

Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 25mg

Coated, oral tablets containing Olmesartan 40mg-Amlodipine 10mg + 2 Hydrochlorothiazide 12.5mg oral tablets. All tablets are given once a day.

DRUG

OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg

Coated, oral tablets containing Olmesartan 40mg-Amlodipine 10mg + 1 Hydrochlorothiazide 12.5mg oral tablet + 1 Hydrochlorothiazide 12.5mg oral, placebo tablet. All tablets are given once a day.

DRUG

OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg

Coated, oral tablets containing Olmesartan 40mg-Amlodipine 10mg + 1 Hydrochlorothiazide 12.5mg oral tablet + 1 Hydrochlorothiazide 12.5mg oral, placebo tablet. All tablets are given once a day.

DRUG

OLM 40mg-AML 10mg-Hydrochlorothiazide 25mg

Coated, oral tablets containing Olmesartan 40mg-Amlodipine 10mg + 2 Hydrochlorothiazide 12.5mg oral tablet. All tablets are given once a day.

Trial Locations (117)

Unknown

Graz

Salzburg

Vienna

Antwerp

Lauwe

Leuven

Liège

Massemen

Oostham

Haskovo

Pleven

Plovdiv

Sofia

Varna

Bílovec

Brno

Havlíčkův Brod

Hodonín

Kladno

Kolín

Ostrava

Ostrava-Vitkovice

Prague

Copenhagen

Frederiksberg

Næstved

Roskilde

Albi

Angers

Brest

Cambrai

Créteil

Dijon

Dinard

Lyon

Nancy

Pessac

Roubaix

Strasbourg

Tiercé

Vandœuvre-lès-Nancy

Villefranche-de-Rouergue

Berlin

Dresden

Einbeck

Hamburg

Magdeburg

München

Straßkirchen

Villingen-Schwenningen

Wermsdorf

Almere Stad

Beek en Donk

Doetinchem

Groningen

Losser

Maastricht

Bytom

Gdansk

Katowice

Krakow

Piotrkow Trybunalski

Puławy

Siemianowice Śląskie

Tarnów

Torun

Warsaw

Wroclaw

Brasov

Bucharest

Cluj-Napoca

Iași

Oradea

Piteşti

Târgovişte

Târgu Mureş

Timișoara

Moscow

Novosibirsk

Orenburg

Ryazan

Saint Petersburg

Saratov

Smolensk

Tomsk

Yaroslavl

Yekaterinburg

Banska Bysterica

Brastislava

Dolný Kubín

Košice

Prešov

Šahy

La Gineta

La Roda

Port de Sagunt

Alicante

Barcelona

Elche

Granada

Madrid

Palma de Mallorca

Seville

Valencia

Vizcaya

Dnipropetrovsk

Donetsk

Ivano-Frankivsk

Kharkiv

Kiev

Lviv

Mykolayiv

Odesa

Simferopol

Uzhhorod

Vinnytsia

Yalta

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT00902538 - Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension | Biotech Hunter | Biotech Hunter